美國商業資訊

標題	作者	回復/查看	最後發表
台灣自主研發資安產品再現競爭力安華聯網AI產品蟬連國際資安競賽7項大獎	admin 2020-3-2	0 / 1148	2020-3-2 10:12 by admin
Boehringer Ingelheim receives positive CHMP opinion for nintedanib for the treat	admin 2020-3-2	0 / 1340	2020-3-2 10:11 by admin
Takeda Receives Positive CHMP Opinion for Subcutaneous Formulation of Vedolizuma	admin 2020-3-2	0 / 1108	2020-3-2 10:08 by admin
Takeda Receives Positive CHMP Opinion for Subcutaneous Formulation of Vedolizuma	admin 2020-3-2	0 / 873	2020-3-2 10:08 by admin
Validity簽訂收購250ok的最終協定以擴大其最佳電子郵件組合	admin 2020-2-28	0 / 1354	2020-2-28 18:32 by admin
電信營運商在GSMA的支持下合作構建電信邊緣雲平台	admin 2020-2-28	0 / 1185	2020-2-28 17:22 by admin
HCL基金會宣佈第五屆HCL Grant得獎組織	admin 2020-2-28	0 / 1093	2020-2-28 17:02 by admin
Velodyne在MODEX 2020上展示用於製造業和供應鏈作業的雷射雷達解決方案	admin 2020-2-28	0 / 1135	2020-2-28 16:49 by admin
Mavenir與Turkcell就OpenRAN展開合作	admin 2020-2-28	0 / 1074	2020-2-28 16:44 by admin
Notice of ABB’s Annual General Meeting on March 26, 2020	admin 2020-2-28	0 / 1057	2020-2-28 16:42 by admin
Energous的革命性WattUp無線充電技術在日本獲得業界首個監管核准	admin 2020-2-28	0 / 1031	2020-2-28 12:44 by admin
GSMA：資通訊科技產業同意以具有里程碑意義的科學途徑達成淨零排放	admin 2020-2-28	0 / 997	2020-2-28 12:40 by admin
NTT DATA建立東協地區歷史文化遺產的數位典藏並向公眾開放	admin 2020-2-28	0 / 1044	2020-2-28 12:35 by admin
HeadSpin宣布以11.6億美元的估值獲得6,000萬美元C輪融資，並任命Nikesh Arora為董事會主席	admin 2020-2-28	0 / 1049	2020-2-28 10:20 by admin
AIG Appoints Jon Hancock Chief Executive Officer, International General Insuranc	admin 2020-2-28	0 / 1031	2020-2-28 10:13 by admin
Boehringer Ingelheim Enters Discovery Stage Collaboration with Trutino Bioscienc	admin 2020-2-28	0 / 1030	2020-2-28 10:11 by admin
矽谷數模的ANX7580顯示控制器為LG雙螢幕手持行動應用提供支援	admin 2020-2-28	0 / 1087	2020-2-28 10:00 by admin
Mavenir和台揚科技宣布推出首個OpenRAN O-RAN介面射頻遠端單元(RRU)產品組合	admin 2020-2-27	0 / 1062	2020-2-27 19:30 by admin
Mavenir攜手業務合作夥伴簡化5G雲端解決方案的部署	admin 2020-2-27	0 / 986	2020-2-27 19:19 by admin
I Squared Capital將把臺灣最大的太陽能平臺售予丸紅	admin 2020-2-27	0 / 1024	2020-2-27 17:16 by admin

16514 1 ...‹‹485 486487488 489 490 491 492 493 494 ››... 826

有新回復

無新回復

熱門主題

關閉主題